{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T15:59:42Z","timestamp":1791907182872,"version":"4.3.4"},"reference-count":171,"publisher":"MDPI AG","issue":"19","license":[{"start":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T00:00:00Z","timestamp":1695859200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>The escalating global prevalence of obesity and its intricate association with the development of hepatocellular carcinoma (HCC) pose a substantial challenge to public health. Obesity, acknowledged as a pervasive epidemic, is linked to an array of chronic diseases, including HCC, catalyzing the need for a comprehensive understanding of its molecular underpinnings. Notably, HCC has emerged as a leading malignancy with rising incidence and mortality. The transition from viral etiologies to the prominence of metabolic dysfunction-associated fatty liver disease (MAFLD)-related HCC underscores the urgent need to explore the intricate molecular pathways linking obesity and hepatic carcinogenesis. This review delves into the interwoven landscape of molecular carcinogenesis in the context of obesity-driven HCC while also navigating using the current therapeutic strategies and future prospects for combating obesity-related HCC. We underscore the pivotal role of obesity as a risk factor and propose an integrated approach encompassing lifestyle interventions, pharmacotherapy, and the exploration of emerging targeted therapies. As the obesity-HCC nexus continues to challenge healthcare systems globally, a comprehensive understanding of the intricate molecular mechanisms and innovative therapeutic strategies is imperative to alleviate the rising burden of this dual menace.<\/jats:p>","DOI":"10.3390\/ijms241914704","type":"journal-article","created":{"date-parts":[[2023,9,29]],"date-time":"2023-09-29T02:47:30Z","timestamp":1695955650000},"page":"14704","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Meeting at the Crossroad between Obesity and Hepatic Carcinogenesis: Unique Pathophysiological Pathways Raise Expectations for Innovative Therapeutic Approaches"],"prefix":"10.3390","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3574-8209","authenticated-orcid":false,"given":"Konstantinos","family":"Arvanitakis","sequence":"first","affiliation":[{"name":"First Department of Internal Medicine, AHEPA University Hospital, Aristotle University of Thessaloniki, 54636 Thessaloniki, Greece"},{"name":"Basic and Translational Research Unit (BTRU), Special Unit for Biomedical Research and Education (BRESU), Faculty of Health Sciences, School of Medicine, Aristotle University of Thessaloniki, 54636 Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1583-1125","authenticated-orcid":false,"given":"Stavros P.","family":"Papadakos","sequence":"additional","affiliation":[{"name":"First Department of Pathology, School of Medicine, National and Kapodistrian University of Athens, 11527 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasileios","family":"Lekakis","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, School of Medicine, National and Kapodistrian University of Athens, Laiko General Hospital, 11527 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5853-1352","authenticated-orcid":false,"given":"Theocharis","family":"Koufakis","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism and Diabetes Centre, First Department of Internal Medicine, Medical School, AHEPA University Hospital, Aristotle University of Thessaloniki, 54636 Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9172-6672","authenticated-orcid":false,"given":"Ioannis G.","family":"Lempesis","sequence":"additional","affiliation":[{"name":"Institute of Metabolism and Systems Research (IMSR), College of Medical and Dental Sciences, University of Birmingham, Birmingham B15 2TT, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleni","family":"Papantoniou","sequence":"additional","affiliation":[{"name":"First Department of Internal Medicine, AHEPA University Hospital, Aristotle University of Thessaloniki, 54636 Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4962-790X","authenticated-orcid":false,"given":"Georgios","family":"Kalopitas","sequence":"additional","affiliation":[{"name":"First Department of Internal Medicine, AHEPA University Hospital, Aristotle University of Thessaloniki, 54636 Thessaloniki, Greece"},{"name":"Basic and Translational Research Unit (BTRU), Special Unit for Biomedical Research and Education (BRESU), Faculty of Health Sciences, School of Medicine, Aristotle University of Thessaloniki, 54636 Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0772-811X","authenticated-orcid":false,"given":"Vasiliki E.","family":"Georgakopoulou","sequence":"additional","affiliation":[{"name":"Department of Pulmonology, Laiko General Hospital, 11527 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9977-4035","authenticated-orcid":false,"given":"Ioanna E.","family":"Stergiou","sequence":"additional","affiliation":[{"name":"Pathophysiology Department, School of Medicine, National and Kapodistrian University of Athens, 11527 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stamatios","family":"Theocharis","sequence":"additional","affiliation":[{"name":"First Department of Pathology, School of Medicine, National and Kapodistrian University of Athens, 11527 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7985-3118","authenticated-orcid":false,"given":"Georgios","family":"Germanidis","sequence":"additional","affiliation":[{"name":"First Department of Internal Medicine, AHEPA University Hospital, Aristotle University of Thessaloniki, 54636 Thessaloniki, Greece"},{"name":"Basic and Translational Research Unit (BTRU), Special Unit for Biomedical Research and Education (BRESU), Faculty of Health Sciences, School of Medicine, Aristotle University of Thessaloniki, 54636 Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,9,28]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"S120","DOI":"10.1038\/ijo.2008.247","article-title":"WHO recognition of the global obesity epidemic","volume":"32","author":"James","year":"2008","journal-title":"Int. J. Obes."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1161\/01.CIR.67.5.968","article-title":"Obesity as an independent risk factor for cardiovascular disease: A 26-year follow-up of participants in the Framingham Heart Study","volume":"67","author":"Hubert","year":"1983","journal-title":"Circulation"},{"key":"ref_3","unstructured":"World Health Organization (2000). Obesity: Preventing and Managing the Global Epidemic: Report of a WHO Consultation, World Health Organization."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1161\/01.cir.0000437739.71477.ee","article-title":"2013 AHA\/ACC\/TOS guideline for the management of overweight and obesity in adults: A report of the American College of cardiology\/American Heart Association task force on practice guidelines and the obesity society","volume":"129","author":"Jensen","year":"2014","journal-title":"Circulation"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"w822","DOI":"10.1377\/hlthaff.28.5.w822","article-title":"Annual medical spending attributable to obesity: Payer-and service-specific estimates","volume":"28","author":"Finkelstein","year":"2009","journal-title":"Health Aff."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Malkin, J.D., Baid, D., Alsukait, R.F., Alghaith, T., Alluhidan, M., Alabdulkarim, H., Altowaijri, A., Almalki, Z.S., Herbst, C.H., and Finkelstein, E.A. (2022). The economic burden of overweight and obesity in Saudi Arabia. PLoS ONE, 17.","DOI":"10.1371\/journal.pone.0264993"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s10198-021-01358-1","article-title":"The economic burden of obesity in Italy: A cost-of-illness study","volume":"23","author":"Pavlova","year":"2022","journal-title":"Eur. J. Health Econ."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1016\/S0140-6736(17)32129-3","article-title":"Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: A pooled analysis of 2416 population-based measurement studies in 128\u00b79 million children, adolescents, and adults","volume":"390","author":"Bentham","year":"2017","journal-title":"Lancet"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/S0140-6736(16)30054-X","article-title":"Trends in adult body-mass index in 200 countries from 1975 to 2014: A pooled analysis of 1698 population-based measurement studies with 19.2 million participants","volume":"387","author":"Bentham","year":"2016","journal-title":"Lancet"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.jhep.2023.03.040","article-title":"Global incidence of non-alcoholic fatty liver disease: A systematic review and meta-analysis of 63 studies and 1,201,807 persons","volume":"79","author":"Le","year":"2023","journal-title":"J. Hepatol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1016\/j.jhep.2021.08.012","article-title":"Epidemiology and risk-stratification of NAFLD-associated HCC","volume":"75","author":"Ioannou","year":"2021","journal-title":"J. Hepatol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/hep.29466","article-title":"Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease","volume":"67","author":"Estes","year":"2018","journal-title":"Hepatology"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","article-title":"A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement","volume":"73","author":"Eslam","year":"2020","journal-title":"J. Hepatol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.3350\/cmh.2022.0367","article-title":"MAFLD: How is it different from NAFLD?","volume":"29","author":"Gofton","year":"2023","journal-title":"Clin. Mol. Hepatol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/S0140-6736(22)01200-4","article-title":"Hepatocellular carcinoma","volume":"400","author":"Vogel","year":"2022","journal-title":"Lancet"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1053\/j.gastro.2022.08.024","article-title":"Dissecting the Tumor Microenvironment to Predict Immunotherapy Response in Hepatocellular Cancer","volume":"163","author":"Pinato","year":"2022","journal-title":"Gastroenterology"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1038\/s41598-021-81671-0","article-title":"Body mass index and cancer risk in patients with type 2 diabetes: A dose\u2013response meta-analysis of cohort studies","volume":"11","author":"Soltani","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1038\/s41416-020-1012-6","article-title":"Association of obesity status and metabolic syndrome with site-specific cancers: A population-based cohort study","volume":"123","author":"Cao","year":"2020","journal-title":"Br. J. Cancer"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1016\/j.ejca.2012.02.063","article-title":"Excess body weight and the risk of primary liver cancer: An updated meta-analysis of prospective studies","volume":"48","author":"Chen","year":"2012","journal-title":"Eur. J. Cancer"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1634\/theoncologist.2012-0066","article-title":"Body mass index and risk of primary liver cancer: A meta-analysis of prospective studies","volume":"17","author":"Wang","year":"2012","journal-title":"Oncologist"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s12933-022-01473-0","article-title":"Glycemic control and atrial fibrillation: An intricate relationship, yet under investigation","volume":"21","author":"Papazoglou","year":"2022","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.jhep.2022.11.010","article-title":"A prospective study on the prevalence of NAFLD, advanced fibrosis, cirrhosis and hepatocellular carcinoma in people with type 2 diabetes","volume":"78","author":"Ajmera","year":"2022","journal-title":"J. Hepatol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S2468-1253(23)00157-7","article-title":"Type 2 diabetes, hepatic decompensation, and hepatocellular carcinoma in patients with non-alcoholic fatty liver disease: An individual participant-level data meta-analysis","volume":"8","author":"Huang","year":"2023","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1053\/j.gastro.2018.08.024","article-title":"Risk of Hepatocellular Cancer in Patients With Non-Alcoholic Fatty Liver Disease","volume":"155","author":"Kanwal","year":"2018","journal-title":"Gastroenterology"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/j.cgh.2012.10.001","article-title":"Association Between Nonalcoholic Fatty Liver Disease and Risk for Hepatocellular Cancer, Based on Systematic Review","volume":"10","author":"White","year":"2012","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1053\/j.gastro.2005.04.014","article-title":"The Natural History of Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study","volume":"129","author":"Adams","year":"2005","journal-title":"Gastroenterology"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1097\/00004836-200304000-00015","article-title":"Risk of cancer in patients hospitalized with fatty liver: A Danish Cohort Study","volume":"36","author":"Jepsen","year":"2003","journal-title":"J. Clin. Gastroenterol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1111\/apt.14937","article-title":"Systematic review with meta-analysis: Risk of hepatocellular carcinoma in non-alcoholic steatohepatitis without cirrhosis compared to other liver diseases","volume":"48","author":"Stine","year":"2018","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1111\/apt.15464","article-title":"Characteristics, aetiologies and trends of hepatocellular carcinoma in patients without cirrhosis: A United States multicentre study Funding information Supported in part by","volume":"50","author":"Gawrieh","year":"2019","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S2468-1253(22)00317-X","article-title":"Global prevalence of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in the overweight and obese population: A systematic review and meta-analysis","volume":"8","author":"Quek","year":"2023","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease\u2014Meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"109924","DOI":"10.1016\/j.diabres.2022.109924","article-title":"Geographic distribution of metabolic syndrome and its components in the general adult population: A meta-analysis of global data from 28 million individuals","volume":"188","author":"Noubiap","year":"2022","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.jcmgh.2021.11.007","article-title":"TM6SF2\/PNPLA3\/MBOAT7 Loss-of-Function Genetic Variants Impact on NAFLD Development and Progression Both in Patients and in In Vitro Models","volume":"13","author":"Longo","year":"2022","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1002\/hep4.1905","article-title":"Gut Dysbiosis and Fecal Calprotectin Predict Response to Immune Checkpoint Inhibitors in Patients With Hepatocellular Carcinoma","volume":"6","author":"Ponziani","year":"2022","journal-title":"Hepatol. Commun."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.metabol.2018.11.014","article-title":"Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics","volume":"92","author":"Polyzos","year":"2019","journal-title":"Metabolism"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Mendez-Sanchez, N., Cruz-Ramon, V., Ramirez-Perez, O., Hwang, J., Barranco-Fragoso, B., and Cordova-Gallardo, J. (2018). New Aspects of Lipotoxicity in Nonalcoholic Steatohepatitis. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19072034"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jcmgh.2021.08.002","article-title":"E-Selectin-Dependent Inflammation and Lipolysis in Adipose Tissue Exacerbate Steatosis-to-NASH Progression via S100A8\/9","volume":"13","author":"Rodrigues","year":"2022","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"4594","DOI":"10.1038\/s41467-022-32283-3","article-title":"A single-cell atlas of the multicellular ecosystem of primary and metastatic hepatocellular carcinoma","volume":"13","author":"Lu","year":"2022","journal-title":"Nat. Commun."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.freeradbiomed.2017.01.023","article-title":"Lipid oxidation products in the pathogenesis of non-alcoholic steatohepatitis","volume":"111","author":"Bellanti","year":"2017","journal-title":"Free Radic. Biol. Med."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.freeradbiomed.2018.11.036","article-title":"Increased plasma levels of the lipoperoxyl radical-derived vitamin E metabolite \u03b1-tocopheryl quinone are an early indicator of lipotoxicity in fatty liver subjects","volume":"131","author":"Torquato","year":"2019","journal-title":"Free Radic. Biol. Med."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1016\/j.clnu.2017.08.031","article-title":"Omega-3 PUFA modulate lipogenesis, ER stress, and mitochondrial dysfunction markers in NASH\u2014Proteomic and lipidomic insight","volume":"37","author":"Okada","year":"2018","journal-title":"Clin. Nutr."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.biochi.2012.12.014","article-title":"Oxidative stress and lipid peroxidation by-products at the crossroad between adipose organ dysregulation and obesity-linked insulin resistance","volume":"95","author":"Murdolo","year":"2013","journal-title":"Biochimie"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1038\/nature09968","article-title":"Aberrant lipid metabolism disrupts calcium homeostasis causing liver endoplasmic reticulum stress in obesity","volume":"473","author":"Fu","year":"2011","journal-title":"Nature"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1053\/jhep.2001.28055","article-title":"High glucose and hyperinsulinemia stimulate connective tissue growth factor expression: A potential mechanism involved in progression to fibrosis in nonalcoholic steatohepatitis","volume":"34","author":"Paradis","year":"2001","journal-title":"Hepatology"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"30708","DOI":"10.1074\/jbc.M113.478685","article-title":"Transforming Growth Factor-\u03b2 (TGF-\u03b2)-mediated Connective Tissue Growth Factor (CTGF) Expression in Hepatic Stellate Cells Requires Stat3 Signaling Activation","volume":"288","author":"Liu","year":"2013","journal-title":"J. Biol. Chem."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Khalid, M., Petroianu, G., and Adem, A. (2022). Advanced Glycation End Products and Diabetes Mellitus: Mechanisms and Perspectives. Biomolecules, 12.","DOI":"10.3390\/biom12040542"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1002\/hep.26491","article-title":"Advanced glycation endproducts induce fibrogenic activity in nonalcoholic steatohepatitis by modulating TNF-\u03b1-converting enzyme activity in mice","volume":"58","author":"Jiang","year":"2013","journal-title":"Hepatology"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1002\/hep4.1906","article-title":"Effect of Omega-3 Polyunsaturated Fatty Acids on Lipid Metabolism in Patients With Metabolic Syndrome and NAFLD","volume":"6","author":"Kosek","year":"2022","journal-title":"Hepatol. Commun."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"100756","DOI":"10.1016\/j.jhepr.2023.100756","article-title":"Saturated fatty acid-enriched small extracellular vesicles mediate a crosstalk inducing liver inflammation and hepatocyte insulin resistance","volume":"5","author":"Alen","year":"2023","journal-title":"JHEP Rep."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.semcancer.2023.04.010","article-title":"Nonalcoholic fatty liver disease and hepatocellular carcinoma:Insights in epidemiology, pathogenesis, imaging, prevention and therapy","volume":"93","author":"Polyzos","year":"2023","journal-title":"Semin. Cancer Biol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1146\/annurev-med-121211-091527","article-title":"Cytokines, Obesity, and Cancer: New Insights on Mechanisms Linking Obesity to Cancer Risk and Progression","volume":"64","author":"Gilbert","year":"2013","journal-title":"Annu. Rev. Med."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/hep.20280","article-title":"Beyond insulin resistance in NASH: TNF-? or adiponectin?","volume":"40","author":"Hui","year":"2004","journal-title":"Hepatology"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1136\/gut.2010.235754","article-title":"Leptin acts as a growth factor for colorectal tumours at stages subsequent to tumour initiation in murine colon carcinogenesis","volume":"60","author":"Endo","year":"2011","journal-title":"Gut"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/nrmicro3344","article-title":"The gut microbiota, bacterial metabolites and colorectal cancer","volume":"12","author":"Louis","year":"2014","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jhep.2014.02.030","article-title":"Carriage of the PNPLA3 rs738409 C &gt;G polymorphism confers an increased risk of non-alcoholic fatty liver disease associated hepatocellular carcinoma","volume":"61","author":"Liu","year":"2014","journal-title":"J. Hepatol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/ajg.2013.476","article-title":"The Effect of PNPLA3 on Fibrosis Progression and Development of Hepatocellular Carcinoma: A Meta-analysis","volume":"109","author":"Singal","year":"2014","journal-title":"Am. J. Gastroenterol."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Nakagawa, H., Hayata, Y., Kawamura, S., Yamada, T., Fujiwara, N., and Koike, K. (2018). Lipid Metabolic Reprogramming in Hepatocellular Carcinoma. Cancers, 10.","DOI":"10.3390\/cancers10110447"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1136\/gutjnl-2021-325918","article-title":"Inflamed and non-inflamed classes of HCC: A revised immunogenomic classification","volume":"72","author":"Montironi","year":"2022","journal-title":"Gut"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/s41575-019-0210-2","article-title":"Adaptive immunity: An emerging player in the progression of NAFLD","volume":"17","author":"Sutti","year":"2020","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/nature16969","article-title":"NAFLD causes selective CD4+ T lymphocyte loss and promotes hepatocarcinogenesis","volume":"531","author":"Ma","year":"2016","journal-title":"Nature"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/s41591-019-0379-5","article-title":"Platelet GPIb\u03b1 is a mediator and potential interventional target for NASH and subsequent liver cancer","volume":"25","author":"Malehmir","year":"2019","journal-title":"Nat. Med."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/s41586-021-03233-8","article-title":"Auto-aggressive CXCR6+ CD8 T cells cause liver immune pathology in NASH","volume":"592","author":"Dudek","year":"2021","journal-title":"Nature"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/s41586-021-03362-0","article-title":"NASH limits anti-tumour surveillance in immunotherapy-treated HCC","volume":"592","author":"Pfister","year":"2021","journal-title":"Nature"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/s41575-019-0145-7","article-title":"From NASH to HCC: Current concepts and future challenges","volume":"16","author":"Anstee","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/s41575-023-00754-7","article-title":"Nonalcoholic steatohepatitis-related hepatocellular carcinoma: Pathogenesis and treatment","volume":"20","author":"Llovet","year":"2023","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1467-789X.2012.01035.x","article-title":"Visceral fat and metabolic inflammation: The portal theory revisited","volume":"13","author":"Item","year":"2012","journal-title":"Obes. Rev."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.it.2017.03.002","article-title":"Immunological Functions of the Omentum","volume":"38","author":"Randall","year":"2017","journal-title":"Trends Immunol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/s41575-018-0069-7","article-title":"Obesity and gastrointestinal cancer: The interrelationship of adipose and tumour microenvironments","volume":"15","author":"Lysaght","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1002\/hep.20965","article-title":"Upregulation of proinflammatory and proangiogenic cytokines by leptin in human hepatic stellate cells","volume":"42","author":"Aleffi","year":"2005","journal-title":"Hepatology"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/obr.12133","article-title":"Peripheral blood leucocyte subclasses as potential biomarkers of adipose tissue inflammation and obesity subphenotypes in humans","volume":"15","author":"Pecht","year":"2014","journal-title":"Obes. Rev."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"8591","DOI":"10.3390\/ijms15058591","article-title":"Evolving concepts in the pathogenesis of NASH: Beyond steatosis and inflammation","volume":"15","author":"Peverill","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.semcancer.2013.07.003","article-title":"Obesity, insulin resistance, NASH and hepatocellular carcinoma","volume":"23","author":"Yu","year":"2013","journal-title":"Semin. Cancer Biol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1136\/gut.2009.199661","article-title":"Non-alcoholic fatty liver disease as a risk factor for hepatocellular carcinoma: Mechanisms and implications","volume":"59","author":"Stickel","year":"2010","journal-title":"Gut"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/obr.12377","article-title":"A role for novel adipose tissue-secreted factors in obesity-related carcinogenesis","volume":"17","author":"Cabia","year":"2016","journal-title":"Obes. Rev."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1002\/hep.21338","article-title":"Leptin-mediated neovascularization is a prerequisite for progression of nonalcoholic steatohepatitis in rats","volume":"44","author":"Kitade","year":"2006","journal-title":"Hepatology"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1158\/1078-0432.CCR-09-1487","article-title":"Suppression of liver tumor growth and metastasis by adiponectin in nude mice through inhibition of tumor angiogenesis and downregulation of rho kinase\/IFN-inducible protein 10\/matrix metalloproteinase 9 signaling","volume":"16","author":"Man","year":"2010","journal-title":"Clin. Cancer Res."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.jhep.2007.03.020","article-title":"Hypoadiponectinemia accelerates hepatic tumor formation in a nonalcoholic steatohepatitis mouse model","volume":"47","author":"Kamada","year":"2007","journal-title":"J. Hepatol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jhep.2008.07.036","article-title":"Activation of lipogenic pathway correlates with cell proliferation and poor prognosis in hepatocellular carcinoma","volume":"50","author":"Yamashita","year":"2009","journal-title":"J. Hepatol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.cell.2009.12.052","article-title":"Dietary and Genetic Obesity Promote Liver Inflammation and Tumorigenesis by Enhancing IL-6 and TNF Expression","volume":"140","author":"Park","year":"2010","journal-title":"Cell"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1126\/science.1140485","article-title":"Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production","volume":"317","author":"Naugler","year":"2007","journal-title":"Science"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/nature07475","article-title":"Frequent in-frame somatic deletions activate gp130 in inflammatory hepatocellular tumours","volume":"457","author":"Rebouissou","year":"2009","journal-title":"Nature"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.cmet.2018.12.012","article-title":"NASH and HCC Are Driven by Different Signaling Pathways with a Common Regulator","volume":"29","author":"Mehal","year":"2019","journal-title":"Cell Metab."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/j.cell.2018.09.053","article-title":"Obesity Drives STAT-1-Dependent NASH and STAT-3-Dependent HCC","volume":"175","author":"Grohmann","year":"2018","journal-title":"Cell"},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Darwish, N.M., Elshaer, M.M.A., Almutairi, S.M., Chen, T.W., Mohamed, M.O., Ghaly, W.B.A., and Rasheed, R.A. (2022). Omega-3 Polyunsaturated Fatty Acids Provoke Apoptosis in Hepatocellular Carcinoma through Knocking Down the STAT3 Activated Signaling Pathway: In Vivo and In Vitro Study. Molecules, 27.","DOI":"10.3390\/molecules27093032"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0092-8674(03)00042-4","article-title":"Liver tumor development. c-Jun antagonizes the proapoptotic activity of p53","volume":"112","author":"Eferl","year":"2003","journal-title":"Cell"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jhep.2009.07.013","article-title":"Inflammatory tumour microenvironment is associated with superior survival in hepatocellular carcinoma patients","volume":"52","author":"Chew","year":"2010","journal-title":"J. Hepatol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1002\/hep.23594","article-title":"Nonalcoholic fatty liver disease and hepatocellular carcinoma: A weighty connection","volume":"51","author":"Starley","year":"2010","journal-title":"Hepatology"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1007\/s001250051393","article-title":"Mitogenic properties of insulin and insulin analogues mediated by the insulin receptor","volume":"40","author":"Christoffersen","year":"1997","journal-title":"Diabetologia"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1002\/hep.510260310","article-title":"Biological effects of human insulin receptor substrate-1 overexpression in hepatocytes","volume":"26","author":"Tanaka","year":"1997","journal-title":"Hepatology"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.cld.2009.07.007","article-title":"NASH and HCC","volume":"13","author":"Page","year":"2009","journal-title":"Clin. Liver Dis."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.cmet.2015.12.015","article-title":"Obesity and Cancer: The Oil that Feeds the Flame","volume":"23","author":"Sun","year":"2016","journal-title":"Cell Metab."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1001\/jama.293.2.194","article-title":"Fasting serum glucose level and cancer risk in Korean men and women","volume":"293","author":"Jee","year":"2005","journal-title":"JAMA"},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Papadakos, S.P., Dedes, N., Kouroumalis, E., and Theocharis, S. (2022). The Role of the NLRP3 Inflammasome in HCC Carcinogenesis and Treatment: Harnessing Innate Immunity. Cancers, 14.","DOI":"10.3390\/cancers14133150"},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"Papadakos, S.P., Stergiou, I.E., Gkolemi, N., Arvanitakis, K., and Theocharis, S. (2023). Unraveling the Significance of EPH\/Ephrin Signaling in Liver Cancer: Insights into Tumor Progression and Therapeutic Implications. Cancers, 15.","DOI":"10.3390\/cancers15133434"},{"key":"ref_96","doi-asserted-by":"crossref","unstructured":"Papadakos, S.P., Arvanitakis, K., Stergiou, I.E., Lekakis, V., Davakis, S., Christodoulou, M.-I., Germanidis, G., and Theocharis, S. (2023). The Role of TLR4 in the Immunotherapy of Hepatocellular Carcinoma: Can We Teach an Old Dog New Tricks?. Cancers, 15.","DOI":"10.3390\/cancers15102795"},{"key":"ref_97","doi-asserted-by":"crossref","unstructured":"Arvanitakis, K., Mitroulis, I., Chatzigeorgiou, A., Elefsiniotis, I., and Germanidis, G. (2023). The Liver Cancer Immune Microenvironment: Emerging Concepts for Myeloid Cell Profiling with Diagnostic and Therapeutic Implications. Cancers, 15.","DOI":"10.3390\/cancers15051522"},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"Arvanitakis, K., Koletsa, T., Mitroulis, I., and Germanidis, G. (2022). Tumor-Associated Macrophages in Hepatocellular Carcinoma Pathogenesis, Prognosis and Therapy. Cancers, 14.","DOI":"10.3390\/cancers14010226"},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"Arvanitakis, K., Mitroulis, I., and Germanidis, G. (2021). Tumor-associated neutrophils in hepatocellular carcinoma pathogenesis, prognosis, and therapy. Cancers, 13.","DOI":"10.3390\/cancers13122899"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"R921","DOI":"10.1016\/j.cub.2020.06.081","article-title":"The tumor microenvironment","volume":"30","author":"Anderson","year":"2020","journal-title":"Curr. Biol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.jhep.2023.02.033","article-title":"Role of immune responses in the development of NAFLD-associated liver cancer and prospects for therapeutic modulation","volume":"79","author":"Yahoo","year":"2023","journal-title":"J. Hepatol."},{"key":"ref_102","doi-asserted-by":"crossref","unstructured":"Ogawa, Y., Imajo, K., Yoneda, M., Kessoku, T., Tomeno, W., Shinohara, Y., Kato, S., Mawatari, H., Nozaki, Y., and Fujita, K. (2013). Soluble CD14 levels reflect liver inflammation in patients with nonalcoholic steatohepatitis. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0065211"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.2353\/ajpath.2009.080999","article-title":"Increased hepatic myeloperoxidase activity in obese subjects with nonalcoholic steatohepatitis","volume":"175","author":"Rensen","year":"2009","journal-title":"Am. J. Pathol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1053\/j.gastro.2012.06.003","article-title":"Dendritic cell populations with different concentrations of lipid regulate tolerance and immunity in mouse and human liver","volume":"143","author":"Ibrahim","year":"2012","journal-title":"Gastroenterology"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"97","DOI":"10.4049\/jimmunol.1501175","article-title":"Progression from Nonalcoholic Fatty Liver to Nonalcoholic Steatohepatitis Is Marked by a Higher Frequency of Th17 Cells in the Liver and an Increased Th17\/Resting Regulatory T Cell Ratio in Peripheral Blood and in the Liver","volume":"196","author":"Rau","year":"2016","journal-title":"J. Immunol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1002\/hep.26937","article-title":"The portal inflammatory infiltrate and ductular reaction in human nonalcoholic fatty liver disease","volume":"59","author":"Gadd","year":"2014","journal-title":"Hepatology"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1097\/MEG.0b013e32831bc3d6","article-title":"Role of liver-infiltrating CD3+CD56+ natural killer T cells in the pathogenesis of nonalcoholic fatty liver disease","volume":"21","author":"Tajiri","year":"2009","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1016\/j.cell.2020.11.009","article-title":"Obesity Shapes Metabolism in the Tumor Microenvironment to Suppress Anti-Tumor Immunity","volume":"183","author":"Ringel","year":"2020","journal-title":"Cell"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"e20210042","DOI":"10.1084\/jem.20210042","article-title":"Suppressive effects of the obese tumor microenvironment on CD8 T cell infiltration and effector function","volume":"219","author":"Dyck","year":"2022","journal-title":"J. Exp. Med."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.4251\/wjgo.v14.i9.1887","article-title":"Nutrition deprivation affects the cytotoxic effect of CD8 T cells in hepatocellular carcinoma","volume":"14","author":"Zhang","year":"2022","journal-title":"World J. Gastrointest. Oncol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/s41423-022-00872-3","article-title":"Aberrant cholesterol metabolic signaling impairs antitumor immunosurveillance through natural killer T cell dysfunction in obese liver","volume":"19","author":"Tang","year":"2022","journal-title":"Cell. Mol. Immunol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.immuni.2022.11.013","article-title":"Prolonged hypernutrition impairs TREM2-dependent efferocytosis to license chronic liver inflammation and NASH development","volume":"56","author":"Wang","year":"2022","journal-title":"Immunity"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of Cancer: The Next Generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1038\/bjc.2015.29","article-title":"Epithelial-to-mesenchymal transition (EMT) induced by inflammatory priming elicits mesenchymal stromal cell-like immune-modulatory properties in cancer cells","volume":"112","author":"Ricciardi","year":"2015","journal-title":"Br. J. Cancer"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1053\/j.gastro.2015.11.002","article-title":"TLR4 Signaling via NANOG Cooperates with STAT3 to Activate Twist1 and Promote Formation of Tumor-Initiating Stem-Like Cells in Livers of Mice","volume":"150","author":"Kumar","year":"2016","journal-title":"Gastroenterology"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/j.cellsig.2016.06.009","article-title":"IL-6\/STAT3 axis initiated CAFs via up-regulating TIMP-1 which was attenuated by acetylation of STAT3 induced by PCAF in HCC microenvironment","volume":"28","author":"Zheng","year":"2016","journal-title":"Cell. Signal."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.7150\/ijbs.45446","article-title":"Cancer-associated fibroblasts induce epithelial-mesenchymal transition via the transglutaminase 2-dependent il-6\/il6r\/stat3 axis in hepatocellular carcinoma","volume":"16","author":"Jia","year":"2020","journal-title":"Int. J. Biol. Sci."},{"key":"ref_118","doi-asserted-by":"crossref","unstructured":"Orel, V.B., Papazoglou, A.S., Tsagkaris, C., Moysidis, D.V., Papadakos, S., Galkin, O.Y., Orel, V.E., and Syvak, L.A. (2022). Nanotherapy based on magneto-mechanochemical modulation of tumor redox state. WIREs Nanomed. Nanobiotechnol., 15.","DOI":"10.1002\/wnan.1868"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.annonc.2021.02.014","article-title":"Updated treatment recommendations for hepatocellular carcinoma (HCC) from the ESMO Clinical Practice Guidelines","volume":"32","author":"Vogel","year":"2021","journal-title":"Ann. Oncol."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.jhep.2021.07.004","article-title":"Systemic treatment of hepatocellular carcinoma: An EASL position paper","volume":"75","author":"Bruix","year":"2021","journal-title":"J. Hepatol."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.jhep.2021.11.018","article-title":"BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update","volume":"76","author":"Reig","year":"2022","journal-title":"J. Hepatol."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"e13298","DOI":"10.1111\/apha.13298","article-title":"Oxygenation of adipose tissue: A human perspective","volume":"228","author":"Lempesis","year":"2020","journal-title":"Acta Physiol."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"100208","DOI":"10.1016\/j.metop.2022.100208","article-title":"Of mice and men: Considerations on adipose tissue physiology in animal models of obesity and human studies","volume":"15","author":"Lempesis","year":"2022","journal-title":"Metab. Open"},{"key":"ref_124","first-page":"16342","article-title":"SGLT-2 inhibitors in obesity and its associated cardiometabolic disorders: Where do we stand?","volume":"132","author":"Vallianou","year":"2022","journal-title":"Pol. Arch. Intern. Med."},{"key":"ref_125","doi-asserted-by":"crossref","unstructured":"Lempesis, I.G., Hoebers, N., Essers, Y., Jocken, J.W.E., Rouschop, K.M.A., Blaak, E.E., Manolopoulos, K.N., and Goossens, G.H. (2022). Physiological Oxygen Levels Differentially Regulate Adipokine Production in Abdominal and Femoral Adipocytes from Individuals with Obesity Versus Normal Weight. Cells, 11.","DOI":"10.3390\/cells11223532"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jhep.2013.08.011","article-title":"Hepatocellular cancer: The impact of obesity, type 2 diabetes and a multidisciplinary team","volume":"60","author":"Dyson","year":"2014","journal-title":"J. Hepatol."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"565","DOI":"10.31083\/j.rcm.2020.04.202","article-title":"Nutrition, dietary habits, and weight management to prevent and treat patients with peripheral artery disease","volume":"21","author":"Sagris","year":"2020","journal-title":"Rev. Cardiovasc. Med."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/S2213-8587(20)30110-8","article-title":"Causes, consequences, and treatment of metabolically unhealthy fat distribution","volume":"8","author":"Stefan","year":"2020","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"808526","DOI":"10.3389\/fendo.2021.808526","article-title":"Hepatocellular Carcinoma and Obesity, Type 2 Diabetes Mellitus, Cardiovascular Disease: Causing Factors, Molecular Links, and Treatment Options","volume":"12","author":"Zhang","year":"2021","journal-title":"Front. Endocrinol."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.jhep.2017.05.016","article-title":"Treatment of NAFLD with diet, physical activity and exercise","volume":"67","author":"Trenell","year":"2017","journal-title":"J. Hepatol."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.2147\/DMSO.S295753","article-title":"Incidence and Survival of Hepatocellular Carcinoma in Type 2 Diabetes Patients with Cirrhosis Who Were Treated with and without Metformin","volume":"14","author":"Tangjarusritaratorn","year":"2021","journal-title":"Diabetes Metab. Syndr. Obes. Targets Ther."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.aohep.2019.11.008","article-title":"Meta-analysis: The efficacy of metformin and other anti-hyperglycemic agents in prolonging the survival of hepatocellular carcinoma patients with type 2 diabetes","volume":"19","author":"Zhou","year":"2020","journal-title":"Ann. Hepatol."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"3206","DOI":"10.1002\/cam4.2142","article-title":"Metformin modifies disparity in hepatocellular carcinoma incidence in men with type 2 diabetes but without chronic liver diseases","volume":"8","author":"Wang","year":"2019","journal-title":"Cancer Med."},{"key":"ref_134","doi-asserted-by":"crossref","unstructured":"Hendryx, M., Dong, Y., Ndeke, J.M., and Luo, J. (2022). Sodium-glucose cotransporter 2 (SGLT2) inhibitor initiation and hepatocellular carcinoma prognosis. PLoS ONE, 17.","DOI":"10.1371\/journal.pone.0274519"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"106261","DOI":"10.1016\/j.phrs.2022.106261","article-title":"The effects of sodium-glucose cotransporter 2 inhibitors on hepatocellular carcinoma: From molecular mechanisms to potential clinical implications","volume":"181","author":"Arvanitakis","year":"2022","journal-title":"Pharmacol. Res."},{"key":"ref_136","doi-asserted-by":"crossref","unstructured":"Lee, H.A., and Kim, H.Y. (2023). Therapeutic Mechanisms and Clinical Effects of Glucagon-like Peptide 1 Receptor Agonists in Nonalcoholic Fatty Liver Disease. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24119324"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.2337\/dc19-1892","article-title":"Effects of novel dual GIP and GLP-1 receptor agonist tirzepatide on biomarkers of nonalcoholic steatohepatitis in patients with type 2 diabetes","volume":"43","author":"Hartman","year":"2020","journal-title":"Diabetes Care"},{"key":"ref_138","doi-asserted-by":"crossref","unstructured":"Arvanitakis, K., Koufakis, T., Kotsa, K., and Germanidis, G. (2022). How Far beyond Diabetes Can the Benefits of Glucagon-like Peptide-1 Receptor Agonists Go? A Review of the Evidence on Their Effects on Hepatocellular Carcinoma. Cancers, 14.","DOI":"10.3390\/cancers14194651"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1053\/j.gastro.2015.04.014","article-title":"Bariatric Surgery Reduces Features of Nonalcoholic Steatohepatitis in Morbidly Obese Patients","volume":"149","author":"Lassailly","year":"2015","journal-title":"Gastroenterology"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.amjsurg.2019.11.001","article-title":"Discussion on: Bariatric surgery is associated with reduction in non-alcoholic steatohepatitis and hepatocellular carcinoma: A propensity matched analysis","volume":"219","author":"Kwak","year":"2020","journal-title":"Am. J. Surg."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1111\/apt.16335","article-title":"Systematic review with meta-analysis: Bariatric surgery reduces the incidence of hepatocellular carcinoma","volume":"53","author":"Ramai","year":"2021","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1002\/ijc.30506","article-title":"Effect of statin on hepatocellular carcinoma in patients with type 2 diabetes: A nationwide nested case-control study","volume":"140","author":"Kim","year":"2017","journal-title":"Int. J. Cancer"},{"key":"ref_143","doi-asserted-by":"crossref","unstructured":"Yang, S.-Y., Wang, C.-C., Chen, K.-D., Liu, Y.-W., Lin, C.-C., Chuang, C.-H., Tsai, Y.-C., Yao, C.-C., Yen, Y.-H., and Hsiao, C.-C. (2021). Statin use is associated with a lower risk of recurrence after curative resection in BCLC stage 0-A hepatocellular carcinoma. BMC Cancer, 21.","DOI":"10.1186\/s12885-021-07796-7"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"2776","DOI":"10.1016\/j.cgh.2019.04.061","article-title":"Daily Aspirin Use Associated With Reduced Risk For Fibrosis Progression In Patients With Nonalcoholic Fatty Liver Disease","volume":"17","author":"Simon","year":"2019","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"3751","DOI":"10.1158\/0008-5472.CAN-21-0758","article-title":"Aspirin in Hepatocellular Carcinoma","volume":"81","author":"Ricciotti","year":"2021","journal-title":"Cancer Res."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1097\/SLA.0000000000001556","article-title":"A Review and Update of Treatment Options and Controversies in the Management of Hepatocellular Carcinoma","volume":"263","author":"Dhir","year":"2016","journal-title":"Ann. Surg."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1245\/s10434-022-12529-6","article-title":"Association of Concurrent Metabolic Syndrome with Long-term Oncological Prognosis Following Liver Resection for Hepatocellular Carcinoma Among Patients with Chronic Hepatitis B Virus Infection: A Multicenter Study of 1753 Patients","volume":"30","author":"Wang","year":"2023","journal-title":"Ann. Surg. Oncol."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.suronc.2016.03.002","article-title":"Hepatocellular carcinoma: From diagnosis to treatment","volume":"25","author":"Grandhi","year":"2016","journal-title":"Surg. Oncol."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1056\/NEJMoa0708857","article-title":"Sorafenib in Advanced Hepatocellular Carcinoma","volume":"359","author":"Llovet","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"ref_150","doi-asserted-by":"crossref","unstructured":"Papadakos, S.P., Ferraro, D., Carbone, G., Frampton, A.E., Vennarecci, G., Kykalos, S., Schizas, D., Theocharis, S., and Machairas, N. (2023). The Emerging Role of Metformin in the Treatment of Hepatocellular Carcinoma: Is There Any Value in Repurposing Metformin for HCC Immunotherapy?. Cancers, 15.","DOI":"10.3390\/cancers15123161"},{"key":"ref_151","doi-asserted-by":"crossref","unstructured":"Papadakos, S.P., Machairas, N., Stergiou, I.E., Arvanitakis, K., Germanidis, G., Frampton, A.E., and Theocharis, S. (2023). Unveiling the Yin-Yang Balance of M1 and M2 Macrophages in Hepatocellular Carcinoma: Role of Exosomes in Tumor Microenvironment and Immune Modulation. Cells, 12.","DOI":"10.3390\/cells12162036"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"C375","DOI":"10.1152\/ajpcell.00379.2020","article-title":"Adipose tissue inflammation and metabolic dysfunction in obesity","volume":"320","author":"Kawai","year":"2021","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1042\/CS20120289","article-title":"NF-\u03baB1 deficiency stimulates the progression of non-alcoholic steatohepatitis (NASH) in mice by promoting NKT-cell-mediated responses","volume":"124","author":"Locatelli","year":"2013","journal-title":"Clin. Sci."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"3892","DOI":"10.1200\/JCO.2011.36.0636","article-title":"Clinical and Prognostic Implications of Plasma Insulin-Like Growth Factor-1 and Vascular Endothelial Growth Factor in Patients With Hepatocellular Carcinoma","volume":"29","author":"Kaseb","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.21037\/tcr-21-2853","article-title":"Prognostic and immunological significance of peroxisome proliferator-activated receptor gamma in hepatocellular carcinoma based on multiple databases","volume":"11","author":"Wang","year":"2022","journal-title":"Transl. Cancer Res."},{"key":"ref_156","doi-asserted-by":"crossref","unstructured":"Zhang, L., Yuan, Q., Li, M., Chai, D., Deng, W., and Wang, W. (2020). The association of leptin and adiponectin with hepatocellular carcinoma risk and prognosis: A combination of traditional, survival, and dose-response meta-analysis. BMC Cancer, 20.","DOI":"10.1186\/s12885-020-07651-1"},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/hep.30036","article-title":"Hepatocellular Carcinoma Is Associated With Gut Microbiota Profile and Inflammation in Nonalcoholic Fatty Liver Disease","volume":"69","author":"Ponziani","year":"2019","journal-title":"Hepatology"},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"134","DOI":"10.14218\/JCTH.2021.00248","article-title":"Biomarkers of Metabolic (Dysfunction)-associated Fatty Liver Disease: An Update","volume":"10","author":"Alharthi","year":"2022","journal-title":"J. Clin. Transl. Hepatol."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"59","DOI":"10.18632\/oncoscience.115","article-title":"Alpha-fetoprotein activates AKT\/mTOR signaling to promote CXCR4 expression and migration of hepatoma cells","volume":"2","author":"Zhu","year":"2015","journal-title":"Oncoscience"},{"key":"ref_160","doi-asserted-by":"crossref","unstructured":"Moldogazieva, N., Mokhosoev, I., Zavadskiy, S., and Terentiev, A. (2021). Proteomic Profiling and Artificial Intelligence for Hepatocellular Carcinoma Translational Medicine. Biomedicines, 9.","DOI":"10.3390\/biomedicines9020159"},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"883","DOI":"10.21873\/anticanres.13189","article-title":"Clinical Significance of Preoperative Hepatocellular Carcinoma With High Lens culinaris Agglutinin-reactive Fraction of Alpha-Fetoprotein, But Low Alpha-Fetoprotein","volume":"39","author":"Yamao","year":"2019","journal-title":"Anticancer Res."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1080\/07357907.2016.1227445","article-title":"Roles and Signaling Pathways of Des-\u03b3-Carboxyprothrombin in the Progression of Hepatocellular Carcinoma","volume":"34","author":"Cui","year":"2016","journal-title":"Cancer Investig."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"6627","DOI":"10.18632\/oncotarget.3113","article-title":"Osteopontin promotes a cancer stem cell-like phenotype in hepatocellular carcinoma cells via an integrin-NF-\u03baB\u2013HIF-1\u03b1 pathway","volume":"6","author":"Cao","year":"2015","journal-title":"Oncotarget"},{"key":"ref_164","first-page":"5299","article-title":"Osteopontin promotes hepatocellular carcinoma progression via the PI3K\/AKT\/Twist signaling pathway","volume":"16","author":"Yu","year":"2018","journal-title":"Oncol. Lett."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S1499-3872(11)60048-9","article-title":"Oncofetal antigen glypican-3 as a promising early diagnostic marker for hepatocellular carcinoma","volume":"10","author":"Yao","year":"2011","journal-title":"Hepatobiliary Pancreat. Dis. Int."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"4431","DOI":"10.2147\/OTT.S246278","article-title":"The Long Noncoding RNA ZFAS1 Potentiates the Development of Hepatocellular Carcinoma via the microRNA-624\/MDK\/ERK\/JNK\/P38 Signaling Pathway","volume":"13","author":"Duan","year":"2020","journal-title":"Onco Targets Ther."},{"key":"ref_167","doi-asserted-by":"crossref","unstructured":"Vongsuvanh, R., van der Poorten, D., Iseli, T., Strasser, S.I., McCaughan, G.W., and George, J. (2016). Midkine Increases Diagnostic Yield in AFP Negative and NASH-Related Hepatocellular Carcinoma. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0155800"},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S1470-2045(12)70233-4","article-title":"Serum DKK1 as a protein biomarker for the diagnosis of hepatocellular carcinoma: A large-scale, multicentre study","volume":"13","author":"Shen","year":"2012","journal-title":"Lancet Oncol."},{"key":"ref_169","doi-asserted-by":"crossref","unstructured":"Fezza, M., Moussa, M., Aoun, R., Haber, R., and Hilal, G. (2019). DKK1 promotes hepatocellular carcinoma inflammation, migration and invasion: Implication of TGF-\u03b21. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0223252"},{"key":"ref_170","first-page":"363","article-title":"Diagnostic and prognostic value of alpha-fetoprotein, des-\u03b3-carboxy prothrombin and squamous cell carcinoma antigen immunoglobulin M complexes in hepatocellular carcinoma","volume":"102","author":"Bertino","year":"2011","journal-title":"Minerva Med."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1111\/liv.13867","article-title":"Diagnostic accuracy of SCCA and SCCA-IgM for hepatocellular carcinoma: A meta-analysis","volume":"38","author":"Liu","year":"2018","journal-title":"Liver Int."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/19\/14704\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:01:08Z","timestamp":1760130068000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/19\/14704"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,28]]},"references-count":171,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2023,10]]}},"alternative-id":["ijms241914704"],"URL":"https:\/\/doi.org\/10.3390\/ijms241914704","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,28]]}}}